A study using an oncogene-induced model of bladder cancer in SPARC WT and SPARC-/- mice, demonstrated that the loss of SPARC promotes the inflammatory phenotype of TAMs (as well as CAFs) through the activation of the transcription factors NF-κB and AP-1. This evidence concerns the gene SPARC and urinary bladder carcinoma.